Seiji Naganuma

1.5k total citations
38 papers, 795 citations indexed

About

Seiji Naganuma is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Seiji Naganuma has authored 38 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Hepatology. Recurrent topics in Seiji Naganuma's work include Liver physiology and pathology (7 papers), Cancer Cells and Metastasis (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Seiji Naganuma is often cited by papers focused on Liver physiology and pathology (7 papers), Cancer Cells and Metastasis (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Seiji Naganuma collaborates with scholars based in Japan, United States and United Kingdom. Seiji Naganuma's co-authors include Hiroshi Itoh, Mutsuo Furihata, Keisuke Taniuchi, Mitsuteru Natsuizaka, Andres J. Klein–Szanto, Hiroshi Nakagawa, Toshiji Saibara, Shinya Ohashi, Phyllis A. Gimotty and Shingo Kagawa and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Seiji Naganuma

38 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seiji Naganuma Japan	16	429	242	236	193	117	38	795
Elisa Gruppioni Italy	15	274 0.6×	216 0.9×	136 0.6×	159 0.8×	95 0.8×	56	703
Ágnes Holczbauer United States	14	353 0.8×	221 0.9×	190 0.8×	206 1.1×	201 1.7×	18	727
Katalin Dezső Hungary	18	326 0.8×	187 0.8×	168 0.7×	243 1.3×	269 2.3×	55	843
Alexandra Drakaki United States	12	430 1.0×	215 0.9×	357 1.5×	126 0.7×	52 0.4×	37	758
Tsung‐Yen Cheng Taiwan	16	264 0.6×	378 1.6×	130 0.6×	193 1.0×	60 0.5×	20	723
Tamako Konkin United States	7	319 0.7×	233 1.0×	213 0.9×	126 0.7×	57 0.5×	8	762
Takehiro Hayashi Japan	15	394 0.9×	333 1.4×	215 0.9×	125 0.6×	279 2.4×	44	937
You‐Wen Qian United States	16	335 0.8×	192 0.8×	137 0.6×	131 0.7×	150 1.3×	53	735
David Smookler Canada	10	240 0.6×	187 0.8×	265 1.1×	87 0.5×	106 0.9×	15	740
Rong-Zhen Luo China	20	737 1.7×	274 1.1×	346 1.5×	216 1.1×	47 0.4×	40	1.2k

Countries citing papers authored by Seiji Naganuma

Since Specialization

Citations

This map shows the geographic impact of Seiji Naganuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Naganuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Naganuma more than expected).

Fields of papers citing papers by Seiji Naganuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Naganuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Naganuma. The network helps show where Seiji Naganuma may publish in the future.

Co-authorship network of co-authors of Seiji Naganuma

This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Naganuma. A scholar is included among the top collaborators of Seiji Naganuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Naganuma. Seiji Naganuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maehara, Osamu, Goki Suda, Mitsuteru Natsuizaka, et al.. (2021). FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma. Cancer Biology & Therapy. 22(5-6). 372–380. 8 indexed citations

Kurabayashi, Atsushi, Chiharu Tanaka, Seiji Naganuma, et al.. (2020). Murine remote ischemic preconditioning suppresses diabetic ketoacidosis by enhancing glycolysis and entry into tricarboxylic acid cycle in the liver. Life Sciences. 253. 117748–117748. 4 indexed citations

Taniuchi, Keisuke, Mutsuo Furihata, Seiji Naganuma, Masahiko Sakaguchi, & Toshiji Saibara. (2019). Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients. PLoS ONE. 14(6). e0217920–e0217920. 15 indexed citations

Kurabayashi, Atsushi, Chiharu Tanaka, Seiji Naganuma, et al.. (2018). Murine remote preconditioning increases glucose uptake and suppresses gluconeogenesis in hepatocytes via a brain-liver neurocircuit, leading to counteracting glucose intolerance. Diabetes Research and Clinical Practice. 139. 288–299. 7 indexed citations

Taniuchi, Keisuke, Mutsuo Furihata, Seiji Naganuma, et al.. (2017). Elevated Expression of SCGB1D2 Predicts Unfavorable Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. JOP, journal of the pancreas. 18(3). 1 indexed citations

Hashida, Yumiko, Kimiko Nakajima, Hideki Nakajima, et al.. (2016). High load of Merkel cell polyomavirus DNA detected in the normal skin of Japanese patients with Merkel cell carcinoma. Journal of Clinical Virology. 82. 101–107. 15 indexed citations

Taniuchi, Keisuke, Mutsuo Furihata, Seiji Naganuma, et al.. (2016). Podocalyxin‐like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin. Cancer Science. 107(10). 1430–1442. 35 indexed citations

Taniuchi, Keisuke, Mutsuo Furihata, Seiji Naganuma, et al.. (2016). Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells. Pancreatology. 16(5). 905–916. 21 indexed citations

Kagawa, Shunsuke, Mitsuteru Natsuizaka, Kelly A. Whelan, et al.. (2014). Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene. 34(18). 2347–2359. 57 indexed citations

10.

Ito, Hideaki, et al.. (2012). Expression of MicroRNAs associated with Gleason grading system in prostate cancer: miR‐182‐5p is a useful marker for high grade prostate cancer. The Prostate. 73(8). 827–834. 52 indexed citations

11.

Ohashi, Shinya, Mitsuteru Natsuizaka, Seiji Naganuma, et al.. (2011). A NOTCH3-Mediated Squamous Cell Differentiation Program Limits Expansion of EMT-Competent Cells That Express the ZEB Transcription Factors. Cancer Research. 71(21). 6836–6847. 89 indexed citations

12.

Naganuma, Seiji, et al.. (2011). Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Cancer Science. 102(12). 2164–2171. 22 indexed citations

13.

Natsuizaka, Mitsuteru, Shinya Ohashi, Seiji Naganuma, et al.. (2011). Abstract 5194: Notch regulates squamous differentiation, cell plasticity and tumor heterogeneity in esophageal carcinoma. Cancer Research. 71(8_Supplement). 5194–5194. 11 indexed citations

14.

Naganuma, Seiji, Sakon Noriki, Makoto Murakami, et al.. (2010). Ruptured mucinous cystic neoplasm with an associated invasive carcinoma of pancreatic head in a pregnant woman: Report of a case and review of literature. Pathology International. 61(1). 28–33. 36 indexed citations

15.

Naganuma, Seiji, et al.. (2009). Effects of bile acids on rat hepatic microsomal type I 11β-hydroxysteroid dehydrogenase. Steroids. 75(2). 164–168. 2 indexed citations

16.

Itoh, Hiroshi, Seiji Naganuma, Kazuhiro Nagaike, et al.. (2006). Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers. Gut. 56(2). 215–226. 7 indexed citations

17.

Kondo, Kazuhiro, Kazuo Chijiiwa, Ichiro Makino, et al.. (2005). Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery. 12(5). 399–404. 52 indexed citations

18.

Naganuma, Seiji, Hiroshi Itoh, Shuichiro Uchiyama, et al.. (2005). Nuclear translocation of H2RSP is impaired in regenerating intestinal epithelial cells of murine colitis model. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(3). 354–360. 5 indexed citations

19.

Naganuma, Seiji, Hiroshi Itoh, Shuichiro Uchiyama, et al.. (2003). Characterization of transcripts generated from mouse hepatocyte growth factor activator inhibitor type 2 (HAI-2) and HAI-2-related small peptide (H2RSP) genes: chimeric mRNA transcribed from both HAI-2 and H2RSP genes is detected in human but not in mouse. Biochemical and Biophysical Research Communications. 302(2). 345–353. 8 indexed citations

20.

Itoh, H., Hiroaki Kataoka, Seiji Naganuma, et al.. (2001). Identification of Hepatocyte Growth Factor Activator Inhibitor Type 2 (HAI-2)-Related Small Peptide (H2RSP): Its Nuclear Localization and Generation of Chimeric mRNA Transcribed from both HAI-2 and H2RSP Genes. Biochemical and Biophysical Research Communications. 288(2). 390–399. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact